Ebola 1 21 (95%), 42 (98%) days
as per online
Ebola 1 21 (95%), 42 (98%) days
as per online sources 5% of ebola victims wont show symptoms even at 21 days, 2% wont show at even 42 days but thats why 1 article shows liberia was expecting to wait 42 days before declaring free
during the incubation period the infection is present in the body so its hard to imagine not being able to detect antibodies or pathogens-yet the implication of the news stories is they are not yet able to until a person is symptomatic.
If this is true it would seem to be a scientific quest to be able to diagnosis during the incubation period so quarantines of 21 days would not be necessary.
Bashers here have implied that tech already exists but if so it its not being used as per news stories.
I was wondering whether this was a hardcore or softcore tech problem.
An example of a hardcore tech problem or something not solvable via tech would be trying via human tech to accelerate an object to the speed of light -since the geometric energy curve to do would make that impossible and run into practical problems also such as a meteorite which would punch only a small hole at 25000 mph would punch a huge hole at higher speed
softcore tech would be PC guys repeatedly saying in the past there was a limit to how much progress could be made w PC chips -only to have that limit broken by new tech time and time again.
it seems w the amazing DNA (it takes a huge room just to fill w volumes on human DNA and it goes beyond the volume required to record the entire genome) RNA ,mitochondria far more efficient than the best human designs etc that the human body would begin reacting during the incubation time frame to the infection and diagnostic methods could detect that reaction.
Again this is outside my fields of interest/comfort zone so maybe I'm missing something.
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...
Continue Reading
Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...
Continue Reading
Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...
Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...
Continue Reading
Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...
Continue Reading
